The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Systematic Drug Repositioning Based on Clinical Side-Effects
Open accessAbstract
Drug repositioning helps fully explore indications for marketed drugs and clinical candidates. Here we show that the clinical side-effects (SEs) provide a human phenotypic profile for the drug, and this profile can suggest additional disease indications. We extracted 3,175 SE-disease relationships by combining the SE-drug relationships from drug labels and the drug-disease relationships from PharmGKB. Many relationships provide explicit repositioning hypotheses, such as drugs causing hypoglycemia are potential candidates for diabetes. We built Naïve Bayes models to predict indications for 145 diseases using the SEs as features. The AUC was above 0.8 in 92% of these models. The method was extended to predict indications for clinical compounds, 36% of the models achieved AUC above 0.7. This suggests that closer attention should be paid to the SEs observed in trials not just to evaluate the harmful effects, but also to rationally explore the repositioning potential based on this "clinical phenotypic assay".
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
Cytoscape 2.8: new features for data integration and network visualization
Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P.-L., & Ideker, T. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btq675 · Cited by 4,830
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816
Cytoscape 2.8: new features for data integration and network
Smoot, E., Ono, K., Ruscheinski, J., Wang, P., & Ideker, T. E. (2011) · Cited by 791
Use of ramipril in preventing stroke: double blind randomised trial
Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B., Davies, R., Ostergren, J., & Probstfield, J. (2002) · BMJ · doi:10.1136/bmj.324.7339.699 · Cited by 420
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Suthram, S., Dudley, J. T., Chiang, A. P., Chen, R., Hastie, T. J., & Butte, A. J. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000662 · Cited by 322
Human Disease-Drug Network Based on Genomic Expression Profiles
Hu, G., & Agarwal, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006536 · Cited by 310
Self-citationSystematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
Chiang, A. P., & Butte, A. J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.103 · Cited by 268
Drug repositioning for orphan diseases
Sardana, D., Zhu, C., Zhang, M., Gudivada, R. C., Yang, L., & Jegga, A. G. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr021 · Cited by 228
Self-citationLuo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr299 · Cited by 206 · cited 1×
“In silico methodologies have helped in mining the drug’s off-target effects [3,4,5,6,7,8], off-system effects (such as, offtarget related gene expression perturbation or downstream pathways) [9,10,11,12,13] and off-phenotypes (i.”
BackgroundSelf-citationTatonetti, N. P., Denny, J. C., Murphy, S. N., Fernald, G. H., Krishnan, G., Castro, V, Yue, P., Tsau, P. S., Kohane, I., Roden, D. M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.83 · Cited by 201
Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients
O’Regan, C., Wu, P., Arora, P., Perri, D., & Mills, E. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.033 · Cited by 182
Management of peripheral arterial disease in primary care
Burns, P., Gough, S., & Bradbury, A. W. (2003) · BMJ · doi:10.1136/bmj.326.7389.584 · Cited by 179
Déchanet‐Merville, J., Merville, P., Bergé, F., Bone‐Mane, G., Taupin, J., Michel, P., Joly, P., Bonneville, M., Potaux, L., & Moreau, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314568 · Cited by 163
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
Burnett, A. L. “., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006) · Urology · doi:10.1016/j.urology.2005.11.045 · Cited by 126
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype
Altman, R. B. (2007) · Nature Genetics · doi:10.1038/ng0407-426 · Cited by 124
Yang, L., Wang, K., Chen, J., Jegga, A. G., Luo, H., Shi, L. M., Wan, C., Guo, X., Qin, S., He, G., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002016 · Cited by 107
Self-citationYang, L., Chen, J., & He, L. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000441 · Cited by 102
Self-citationXie, L., Wang, J., & Bourne, P. E. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030217 · Cited by 89
Quan, M., Zhang, N., Wang, Y.-Y., Zhang, T., & Yang, Z. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.026 · Cited by 89
Computational prediction of human drug metabolism
Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 87
Erythropoietic and hepatic porphyrias
Groß, U., Hoffmann, G. F., & Manfred Otto, D. O. S. S. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005645624262 · Cited by 83
Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data
Pouliot, Y., Chiang, A. P.-F., & Butte, A. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.81 · Cited by 80
Yang, L., Luo, H., Chen, J., Xing, Q., & He, L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp312 · Cited by 67
Self-citationAbolfazli, R., Hosseini, M., Ghanizadeh, A. J., Ghaleiha, A., Tabrizi, M. H., Raznahan, M., Golalizadeh, M., & Akhondzadeh, S. (2011) · Depression and Anxiety · doi:10.1002/da.20801 · Cited by 60
The role of translational bioinformatics in drug discovery
Buchan, N. S., Rajpal, D. K., Webster, Y., Alatorre, C., Gudivada, R. C., Zheng, C., Sanséau, P., & Koehler, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.002 · Cited by 59
Immunological consequences of ischemic stroke: Immunosuppression and autoimmunity
Vogelgesang, A., & Dressel, A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.023 · Cited by 58
Wallach, I., Jaitly, N., & Lilien, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012063 · Cited by 55
Chiba, S., Numakawa, T., Ninomiya, M., Yoon, H. S., & Kunugi, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1894-8 · Cited by 42
Kernohan, A. F. B., Sattar, N. A., Hilditch, T., Cleland, S. J., SMALL, M. P., Lumsden, M. A., Connell, J., & Petrie, J. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02679.x · Cited by 40
Complaints of Cold Extremities among Patients on Antihypertensive Treatment
Feleke, E., Lyngstam, O., Råstam, L., & Rydén, L. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03755.x · Cited by 31
Yang, L., Xu, L., & He, L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp369 · Cited by 28
Self-citationIbarra-Lara, L., Cervantes-Pérez, L. G., Pérez‐Severiano, F., del Valle‐Mondragón, L., Rubio-Ruiz, M. E., Soria‐Castro, E., Pastelín-Hernández, G. S., Sánchez-Aguilar, M., Martínez‐Lazcano, J. C., & Sánchez-Mendoza, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.039 · Cited by 25
Landriscina, M., Bagalá, C., Piscazzi, A., Schinzari, G., Quirino, M., Fabiano, A., Bianchetti, S., Cassano, A., Sica, G., & Barone, C. (2009) · The Prostate · doi:10.1002/pros.20923 · Cited by 24
Over-the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet
Kendig, E. L., Schneider, S. N., Clegg, D. J., Genter, M. B., & Shertzer, H. G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.001 · Cited by 22
Sun, R. C. F., Shek, D. T. L., & Siu, A. M. H. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.126 · Cited by 21
PPAR γ Agonists: Blood Pressure and Edema
Blazer‐Yost, B. L. (2009) · PPAR Research · doi:10.1155/2010/785369 · Cited by 13
Cited by
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
A survey of current trends in computational drug repositioning
Li, J., Zheng, S., Chen, B., Butte, A. J., Swamidass, S. J., & Lu, Z. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv020 · Cited by 555
Drug repurposing from the perspective of pharmaceutical companies
Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., Kusko, R., Zeskind, B., Risso, S., Kagan, E., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13798 · Cited by 429
Metadata
- Authors
- Yang, L., & Agarwal, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-21
- Volume
- 6
- Issue
- 12
- Pages
- e28025
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2020132970
- Cited by
- 266
- References
- 43
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.